Selected article for: "active site and dengue virus"

Author: Lim, Liangzhong; Dang, Mei; Roy, Amrita; Kang, Jian; Song, Jianxing
Title: Curcumin Allosterically Inhibits the Dengue NS2B-NS3 Protease by Disrupting Its Active Conformation
  • Cord-id: lve4xnik
  • Document date: 2020_9_29
  • ID: lve4xnik
    Snippet: [Image: see text] Flaviviruses including dengue virus and Zika virus encode a unique two-component NS2B-NS3 protease essential for maturation/infectivity, thus representing a key target for designing antiflavivirus drugs. Here, for the first time, by NMR and molecular docking, we reveal that curcumin allosterically inhibits the dengue protease by binding to a cavity with no overlap with the active site. Further molecular dynamics simulations decode that the binding of curcumin leads to unfolding
    Document: [Image: see text] Flaviviruses including dengue virus and Zika virus encode a unique two-component NS2B-NS3 protease essential for maturation/infectivity, thus representing a key target for designing antiflavivirus drugs. Here, for the first time, by NMR and molecular docking, we reveal that curcumin allosterically inhibits the dengue protease by binding to a cavity with no overlap with the active site. Further molecular dynamics simulations decode that the binding of curcumin leads to unfolding/displacing the characteristic β-hairpin of the C-terminal NS2B and consequently disrupting the closed (active) conformation of the protease. Our study identified a cavity most likely conserved in all flaviviral NS2B-NS3 proteases, which could thus serve as a therapeutic target for the discovery/design of small-molecule allosteric inhibitors. Moreover, as curcumin has been used as a food additive for thousands of years in many counties, it can be directly utilized to fight the flaviviral infections and as a promising starting for further design of potent allosteric inhibitors.

    Search related documents:
    Co phrase search for related documents
    • active site and long range: 1, 2, 3, 4, 5
    • active site and low energy: 1, 2, 3, 4, 5, 6, 7, 8
    • active site inhibitor and long range: 1, 2
    • active state and long range: 1
    • active state and low energy: 1
    • long range and low energy: 1, 2